Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Connection

Richard Schulick to SEER Program

This is a "connection" page, showing publications Richard Schulick has written about SEER Program.

 
Connection Strength
 
 
 
0.475
 
  1. Schulick RD. Undertreatment of patients with early-stage hepatocellular carcinoma: Comment on "Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma". Arch Surg. 2010 Dec; 145(12):1163-4.
    View in: PubMed
    Score: 0.090
  2. Mayo SC, Shore AD, Nathan H, Edil B, Wolfgang CL, Hirose K, Herman J, Schulick RD, Choti MA, Pawlik TM. National trends in the management and survival of surgically managed gallbladder adenocarcinoma over 15 years: a population-based analysis. J Gastrointest Surg. 2010 Oct; 14(10):1578-91.
    View in: PubMed
    Score: 0.088
  3. Nathan H, Raut CP, Thornton K, Herman JM, Ahuja N, Schulick RD, Choti MA, Pawlik TM. Predictors of survival after resection of retroperitoneal sarcoma: a population-based analysis and critical appraisal of the AJCC staging system. Ann Surg. 2009 Dec; 250(6):970-6.
    View in: PubMed
    Score: 0.084
  4. Nathan H, Pawlik TM, Wolfgang CL, Choti MA, Cameron JL, Schulick RD. Trends in survival after surgery for cholangiocarcinoma: a 30-year population-based SEER database analysis. J Gastrointest Surg. 2007 Nov; 11(11):1488-96; discussion 1496-7.
    View in: PubMed
    Score: 0.072
  5. Mayo SC, Nathan H, Cameron JL, Olino K, Edil BH, Herman JM, Hirose K, Schulick RD, Choti MA, Wolfgang CL, Pawlik TM. Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent. Cancer. 2012 May 15; 118(10):2674-81.
    View in: PubMed
    Score: 0.024
  6. Mayo SC, Shore AD, Nathan H, Edil BH, Hirose K, Anders RA, Wolfgang CL, Schulick RD, Choti MA, Pawlik TM. Refining the definition of perioperative mortality following hepatectomy using death within 90 days as the standard criterion. HPB (Oxford). 2011 Jul; 13(7):473-82.
    View in: PubMed
    Score: 0.023
  7. Nathan H, Schulick RD, Choti MA, Pawlik TM. Predictors of survival after resection of early hepatocellular carcinoma. Ann Surg. 2009 May; 249(5):799-805.
    View in: PubMed
    Score: 0.020
  8. Nathan H, Wolfgang CL, Edil BH, Choti MA, Herman JM, Schulick RD, Cameron JL, Pawlik TM. Peri-operative mortality and long-term survival after total pancreatectomy for pancreatic adenocarcinoma: a population-based perspective. J Surg Oncol. 2009 Feb 01; 99(2):87-92.
    View in: PubMed
    Score: 0.020
  9. Nathan H, Aloia TA, Vauthey JN, Abdalla EK, Zhu AX, Schulick RD, Choti MA, Pawlik TM. A proposed staging system for intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2009 Jan; 16(1):14-22.
    View in: PubMed
    Score: 0.019
  10. Sonnenday CJ, Dimick JB, Schulick RD, Choti MA. Racial and geographic disparities in the utilization of surgical therapy for hepatocellular carcinoma. J Gastrointest Surg. 2007 Dec; 11(12):1636-46; discussion 1646.
    View in: PubMed
    Score: 0.018
  11. Slidell MB, Chang DC, Cameron JL, Wolfgang C, Herman JM, Schulick RD, Choti MA, Pawlik TM. Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis. Ann Surg Oncol. 2008 Jan; 15(1):165-74.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)